Pay in 4 interest-free payments of $6.46 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
It is about biology
Investors and clinicians alike have been closely watching Lilly's progress, especially in comparison to other leading treatments
doi:10.3390/microorganisms9030543 31
It will offer a glimpse into the future as key trends play out that will shape how obesity is viewed, diagnosed and treated, while healthcare systems grapple with this formidable challenge
Safety of GLP-1 Receptor Agonists and Other Second-Line Antidiabetics in Early Pregnancy
US$ 20.27
US$ 21.27
US$ 26.32
US$ 27.26
US$ 27.52
